Estrogen-dependent growth and estrogen receptor (ER)-α concentration in T47D breast cancer cells are inhibited by VACM-1, a cul 5 gene

Molecular and Cellular Biochemistry

Volumn 301, Issue 1-2, 2007, Pages 13-20

  Johnson, Alyssa E ^a   Le, Isabelle P ^a   Buchwalter, Abby ^a   Burnatowska Hledin, Maria A ^a  

^a HOPE COLLEGE   (United States)

Author keywords

17 Estradiol; Estrogen receptor; Mitogen activated protein kinase; Vasopressin activated calcium mobilizing protein

Indexed keywords

COMPLEMENTARY DNA; CULLIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; VASOPRESSION ACTIVATED CALCIUM MOBILIZING RECEPTOR 1;

ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PROTEIN LOCALIZATION; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CULLIN PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 34250171734     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9392-3     Document Type: Article

References (44)

1. Gruber C, Tschugguel W, Schneeberger C, Huber J (2002) Mechanisms of disease: Production and actions of estrogen. N Engl J Med 346:340-352
2. Banerjee SK, Islam A, Banerjee S (2005) The regulatory roles of estrogen in carcinogenesis: An overview. In: Preuss HG, Bagchi D (eds) Phytopharmaceuticals in cancer chemoprevention. CRC Press, LLC, Boca Raton, FL, pp 105-121
3. Losordo DW, Isner JM (2001) Estrogen and angiogenesis: A review. Vasc Biol 21:6-12
4. Albrecht ED, Babischkin JS, Lidor Y, Anderson LD, Udoff LC, Pepe GJ (2003) Effect of estrogen on angiogenesis in co-cultures of human endometrial cells and microvascular endothelial cells. Hum Reprod 18:2039-2047
5. Guo X, Razandi M, Pedram A, Kassab G, Levin ER (2005) Estrogen induces vascular wall dilation. J Biol Chem 280:19704-19710
6. Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P (1993) Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 342:133-136
7. Mendelsohn ME, Karas RH (2005) Molecular and cellular basis of cardiovascular gender differences. Science 308:1583-1587
8. Lippman M, Bolan G, Huff K (1976) The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36:4602-4609
9. Gao X, Loggie BW, Nawaz Z (2002) The roles of sex steroid receptor coregulators in cancer. Mol Cancer 1:7-14
10. Giguere V, Yang N, Segui P, Evans RM (1988) Identification of a new class of steroid hormone receptors. Nature 331:91-94
11. Debies MT, Welch DR (2002) Genetic basis of human breast cancer metastasis. J Mammary Gland Biol Neoplasia 6:441-451
12. Pedram A, Razandi M, Aitkenhead M, Hughes CCW, Levin ER (2002) Integration of the non-genomic and genomic actions of estrogen. J Biol Chem 277:50768-50775
13. Pratt MA, Satunaratnam A, Novosad DM (1998) Estrogen activates raf-1 kinase and induces expression of Egr-1 in MCF-7 breast cancer cells. Mol Cell Biochem 189:119-125
14. Klinge CM, Blankenship KA, Risinger KE, Bhatnagar S, Noisin EL, Sumanasekera WK, Zhao L, Brey DM, Keynton RS (2005) Reservatrol and estradiol rapidly activate MAPK signaling through estrogen receptors α and β in endothelial cells. J Biol Chem 280:7460-7468
15. Sumi D, Ignarro L (2003) Estrogen-related receptor α up-regulates endothelial nitric oxide synthase expression. PNAS 100:4451-4456
16. Masuyama H, Hiramatsu Y (2004) Involvement of suppressor for Gal 1 in the ubiquitin/proteasome-mediated degradation of estrogen receptors. J Biol Chem 279:12020-12026
17. Fan M, Bigsby RM, Nephew KP (2003) The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)- α and essential for the antiproliferative activity of ICI 182,780 in ERα-positive breast cancer cells. Mol Endocrinol 17:356-365
18. Wormke M, Stoner M, Saville B, Walker K, Abdelrahim M, Burghardt R, Safe S (2003) The aryl hydrocarbon receptor mediates degradation of estrogen receptor α through activation of proteasomes. Mol Cell Biol 23:1843-1855
19. Maaroufi Y, Lacroix M, Lespagnard L, Journé F, Larsimont D, Leclercq G (2000) Estrogen receptor of primary breast cancers: Evidence for intracellular proteolysis. Breast Cancer Res 2:444-454
20. Dobrzycka KM, Townson SM, Jiang S, Oesterreich S (2003) Estrogen receptor corepressors- a role in human breast cancer? Endocr Relat Cancer 10:517-536
21. Hori T, Osaka F, Miyamoto C, Okabayashi K, Shimbara N, Kato S, Tanaka K (1999) Covalent modification of all members of human cullin family proteins by NEDD8. Oncogene 18:6829-6834
22. Kipreos ET, Lander LE, Wing JP, He WW, Hedgecock EM (1996) Cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family. Cell 85:829-839
23. Mathias NS, Johnson L, Winey M, Adams AEM, Goetsch L, Pringle JR, Byers B, Goebl MG (1996) Cdc53p acts in concert with Cdc4p and Cdc34p to control the G1to-S-phase transition and identifies a conserved family of proteins. Mol Cell Biol 16:6634-6643
24. Petroski MD, Deshaies RJ (2005) Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 6:9-20
25. Burnatowska-Hledin M, Spielman WS, Smith WL, Shi P, Meyer JM, Dewitt DL (1995) Expression cloning of an AVP-activated calcium-mobilizing receptor from rabbit kidney medulla. Am J Physiol 268:1198-1210
26. Byrd PJ, Stankovic T, McConville CM, Smith AD, Cooper PR Taylor AMR (1997) Identification and analysis of expression of human VACM-1, a cullin gene family member located on chromosome 11q22-23. Genome Res 7:71-75
27. Burnatowska-Hledin M, Kossoris J, Van Dort C, Shearer RL, Zhao P, Murrey DA, Abbot JL, Kan CE, Barney C (2004) T47D breast cancer cell growth is inhibited by expression of VACM-1, a cul-5 gene. Biochem Biophys Res Commun 319:817-825
28. Van Dort C, Zhao P, Parmelee K, Capps B, Poel A, Listenberger L, Kossoris J, Wasilevich B, Murrey D, Clare P, Burnatowska-Hledin M (2003) VACM-1, a cul-5 gene, inhibits cellular growth by a mechanism that involves MAPK and p53 signaling pathways. Am J Physiol Cell 285:1386-1396
29. deJager T, Pelzer T, Müller-Botz S, Imam A, Muck J, Neyses L (2001) Mechanisms of estrogen receptor action in the myocardium. J Biol Chem 276:27873-27880
30. Otsuki T, Yamada O, Kurebayashi J, Moriya T, Sakaguchi H, Kunisue H, Yata K, Uno M, Yawata Y, Ueki A (2000) Estrogen receptors in human myeloma cells. Cancer Res 60:1434-1441
31. Font de Mora J, Brown M (2000) AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol 20:5041-5047
32. Lee H, Bai W (2002) Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation. Mol Cell Biol 22:5835-5845
33. Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S, Brenner HJ (1979) Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15:659-670
34. Ronen D, Altstock RT, Firon M, Mittelman L, Sobe T, Resau JH, VandeWoude GF, Tsarfaty I (1999) Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells. Cell Growth Differ 10:131-140
35. Orlowski RZ, Dees EC (2003) Applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer. Breast Cancer Res 5:1-7
36. Le Goff P, Montano M, Schodin D, Katzenellenbogen B (1994) Phosphorylation of the human estrogen receptor. J Biol Chem 269:4458-4466
37. Joel P, Traish A, Lannigan A (1995) Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Mol Endocrinol 9:1041-1052
38. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki P, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P (1995) Activation of the estrogen receptor through phosphorylation of mitogen-activated protein kinase. Science 270:1491-1494
39. Bunone G, Briand P, Miksicek R, Picard D (1996) Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15:2174-2183
40. Joel P, Traish A, Lannigan DA (1998) Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/22 mitogen-activated protein kinase. J Biol Chem 273:13317-13323
41. Querido E, Blanchette P, Yan Q, Kamura T, Morrison M, Boivin D, Kaelin WG, Conaway RC, Conaway JW, Branton PE (2001) Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev 15:3104-3117
42. Lange C, Shen T, Horwitz K (2000) Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteosome. PNAS 97:1032-1037
43. Stronach EA, Sellar GC, Blenkiron C, Rabiasz GJ, Taylor KJ, Miller EP, Massie CE, Al-Nafussi A, Smyth JF, Porteous DJ, Gabra H (2003) Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression. Cancer Res 63:8648-8655
44. Fay MJ, Longo KA, Karathanasis GA et al (2003) Analysis of cul-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissues. Mol Cancer 2(40). Available from: http://www.molecular-cancer.com/content/2/1/40